Hollencrest Capital Management acquired a new position in SPDR Bloomberg Barclays 1-3 Month T-Bill ETF (NYSEARCA:BIL – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 1,098 shares of the company’s stock, valued at approximately $101,000.
Several other large investors also recently bought and sold shares of the company. Bogart Wealth LLC acquired a new stake in shares of SPDR Bloomberg Barclays 1-3 Month T-Bill ETF in the first quarter worth approximately $42,000. Kozak & Associates Inc. purchased a new stake in shares of SPDR Bloomberg Barclays 1-3 Month T-Bill ETF during the first quarter worth $45,000. WR Wealth Planners LLC purchased a new stake in shares of SPDR Bloomberg Barclays 1-3 Month T-Bill ETF during the second quarter worth $51,000. Mather Group LLC. purchased a new position in shares of SPDR Bloomberg Barclays 1-3 Month T-Bill ETF in the first quarter worth about $58,000. Finally, Innealta Capital LLC purchased a new position in shares of SPDR Bloomberg Barclays 1-3 Month T-Bill ETF in the second quarter worth about $66,000.
SPDR Bloomberg Barclays 1-3 Month T-Bill ETF Stock Up 0.0 %
Shares of NYSEARCA BIL opened at $91.73 on Friday. SPDR Bloomberg Barclays 1-3 Month T-Bill ETF has a 12-month low of $91.21 and a 12-month high of $91.85. The company has a 50-day moving average of $91.64 and a 200 day moving average of $91.62.
About SPDR Bloomberg Barclays 1-3 Month T-Bill ETF
The SPDR Bloomberg 1-3 Month T-Bill ETF (BIL) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a market-weighted index of all publicly issued zero-coupon US Treasury bills with a maturity of at least 1 month, but less than 3 months. BIL was launched on May 25, 2007 and is managed by State Street.
Further Reading
- Five stocks we like better than SPDR Bloomberg Barclays 1-3 Month T-Bill ETF
- Conference Calls and Individual Investors
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Roth IRA Calculator: Calculate Your Potential Returns
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Want to see what other hedge funds are holding BIL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR Bloomberg Barclays 1-3 Month T-Bill ETF (NYSEARCA:BIL – Free Report).
Receive News & Ratings for SPDR Bloomberg Barclays 1-3 Month T-Bill ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR Bloomberg Barclays 1-3 Month T-Bill ETF and related companies with MarketBeat.com's FREE daily email newsletter.